Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Tetracycline may be effective in preventing skin rash that is caused by treatment
with drugs such as gefitinib or cetuximab.
PURPOSE: This randomized clinical trial is studying tetracycline to see how well it works
compared to placebo in preventing skin rash in patients who are receiving drugs such as
gefitinib or cetuximab for cancer.